Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200-Day Moving Average - Time to Sell?

Key Points

• Utah Medical Products' stock crossed above its 200-day moving average, trading as high as $65.68 and last at $65.42 versus a 200-day MA of $61.15, suggesting a potential technical breakout.
• Weiss Ratings upgraded the stock to a "hold" from a "sell", and MarketBeat shows a consensus rating of Hold.
• Recent results and income metrics are solid: the company reported $0.82 EPS on $8.72M in revenue with a 28.9% net margin, and it pays a $1.24 annual dividend (about a 1.9% yield).

Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $61.15 and traded as high as $65.68. Utah Medical Products shares last traded at $65.42, with a volume of 6,799 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Utah Medical Products from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, February 25th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Utah Medical Products has a consensus rating of "Hold".

Utah Medical Products Stock Performance

The company's fifty day moving average is $65.56 and its two-hundred day moving average is $61.15. The firm has a market cap of $208.04 million, a price-to-earnings ratio of 19.36 and a beta of 0.35.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its quarterly earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 9.17% and a net margin of 28.90%.The firm had revenue of $8.72 million during the quarter.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 3rd. Shareholders of record on Tuesday, March 17th were issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, March 17th. Utah Medical Products's dividend payout ratio is currently 36.69%.

Hedge Funds Weigh In On Utah Medical Products

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Segall Bryant & Hamill LLC acquired a new stake in Utah Medical Products during the 3rd quarter valued at approximately $726,000. Everett Harris & Co. CA raised its holdings in Utah Medical Products by 24.1% in the fourth quarter. Everett Harris & Co. CA now owns 21,344 shares of the medical instruments supplier's stock valued at $1,194,000 after acquiring an additional 4,151 shares in the last quarter. Minerva Advisors LLC raised its holdings in Utah Medical Products by 0.6% in the fourth quarter. Minerva Advisors LLC now owns 93,615 shares of the medical instruments supplier's stock valued at $5,239,000 after acquiring an additional 557 shares in the last quarter. LSV Asset Management boosted its stake in Utah Medical Products by 3.9% during the 4th quarter. LSV Asset Management now owns 13,474 shares of the medical instruments supplier's stock valued at $754,000 after acquiring an additional 500 shares during the last quarter. Finally, Cardinal Capital Management boosted its stake in Utah Medical Products by 1.9% during the 4th quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier's stock valued at $1,394,000 after acquiring an additional 459 shares during the last quarter. 69.60% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.